Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Abstract

loading...

About

This paper, published in 1950, received 1.2k indexed citations. Written by Kenneth S. Thress, Cloud P. Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos and Yanan Kuang covering the research area of Cancer Research, Pulmonary and Respiratory Medicine and Oncology. It is primarily cited by scholars working on Pulmonary and Respiratory Medicine (885 citations), Oncology (690 citations) and Molecular Biology (623 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm.3854 →

Countries where authors are citing Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Since Specialization
Citations

This map shows the geographic impact of Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M more than expected).

Fields of papers citing Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm.3854.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026